We assessed serum levels of MCP-1 as a potential biomarker for the therapeutic effects of hMSCs in mice fed with a high-fat (HF) diet, which is an established model of ubiquitous atherosclerotic change, to clarify the role of MCP-1 and hMSCs in atherosclerosis. This evidence concerns the gene CCL2 and atherosclerosis.